Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose Kaletra in children
PACTR2008060000852767Unknown
- Sponsor
- University of Cape Town
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV) and Tuberculosis (TB) (2 arms), sponsored by University of Cape Town. Primary endpoint: Trough lopinavir concentration. Status: unknown.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR2008060000852767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2008060000852767.